Science
Mechanism of Action
As a singular chain recombinant fusion peptide, R-MUSSEL POLYPEPTIDE-1 R-MUSSEL OLIGOPEPTIDE-1 SH-POLYPEPTIDE-48 is believed to function by emulating the biological activities of epidermal and fibroblast growth factors. Its sh-Oligopeptide-1 component, akin to Epidermal Growth Factor (EGF), is anticipated to accelerate dermal healing, reinforce skin barrier integrity, and temper inflammatory responses. Concurrently, the sh-Polypeptide-1 aspect, similar to Basic Fibroblast Growth Factor (bFGF), is expected to stimulate fibroblast proliferation, which is crucial for the biosynthesis of collagen and elastin, thereby contributing to skin renewal and firmness.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Specific safety data, including GHS Classification, oral/parenteral, dermal, or inhalation toxicity for R-MUSSEL POLYPEPTIDE-1 R-MUSSEL OLIGOPEPTIDE-1 SH-POLYPEPTIDE-48, have not been determined or are unavailable. While sh-oligopeptide-1 is approved for cosmetic use in various concentrations, its long-term risks remain unknown. It is important to note that active EGF is not categorized as a cosmetic ingredient but rather as a potent unauthorized pharmaceutical.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This recombinant fusion peptide demonstrates theoretical potential for skin regeneration and anti-aging benefits, yet its precise efficacy, optimal usage, and comprehensive safety profile for the specific fusion peptide are not substantiated by direct clinical studies.
Related
Similar Ingredients
Finding similar ingredients…